These novel features of OC were demonstrated through its ability to downregulatethe estrogen receptors in BT-474 breast cancer cells both in vitro and in vivo, and by suppressing the growth of hormone-dependent breast cancer [73]. The gene discussed is ESR1; the disease is breast carcinoma.